g2p id,gene symbol,gene mim,hgnc id,previous gene symbols,disease name,disease mim,disease MONDO,allelic requirement,cross cutting modifier,confidence,variant consequence,variant types,molecular mechanism,molecular mechanism support,molecular mechanism categorisation,molecular mechanism evidence,phenotypes,publications,additional mined publications,panel,comments,date of last review,review
G2P00027,BRIP1,605882,20473,BACH1; FANCJ; OF,BRIP1-related Fanconi anemia,609054,MONDO:0012187,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000568; HP:0001263; HP:0001511; HP:0003221; HP:0005528; HP:0007565; HP:0008897; HP:0009778,16116424,16116423; 26968956; 27869810; 33028645; 33224012; 33546375; 37582649; 40649708,DD; Cancer,,2025-01-28 23:03:26+00:00,
G2P00049,XPC,613208,12816,RAD4; XPCC,XPC-related xeroderma pigmentosum,278720,MONDO:0010211,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000491; HP:0000509; HP:0000613; HP:0000621; HP:0000656; HP:0000992; HP:0001009; HP:0001010; HP:0001029; HP:0002671; HP:0003079; HP:0004334; HP:0006739; HP:0011463; HP:0012056,11121128; 11511294; 14662655; 19478817; 8298653; 9804340,10604143; 20816579; 23143338; 23984341; 25256075; 26227012; 27387384; 27982466; 28255305; 28615033; 29356054; 30101995; 31923348; 33672602; 35235204; 38003022; 38422792; 40252274,DD; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P00165,NOP10,606471,14378,MGC70651; NOLA3; NOP10P,NOP10-related dyskeratosis congenita,224230,MONDO:0009136,biallelic_autosomal,,moderate,absent gene product; altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,loss of function,inferred,,,HP:0000007; HP:0000252; HP:0000579; HP:0000653; HP:0000670; HP:0000691; HP:0000939; HP:0000953; HP:0001249; HP:0001395; HP:0001792; HP:0001873; HP:0001915; HP:0002043; HP:0002164; HP:0002165; HP:0002206; HP:0002209; HP:0002745; HP:0003812; HP:0004808; HP:0005528; HP:0009926; HP:0012182; HP:0030438; HP:0030442,17507419,17825470; 19327580; 22160078; 30047419; 32139460; 32554502,DD; Cancer,,2025-03-14 11:49:26+00:00,
G2P00177,DDB2,600811,2718,DDBB; FLJ34321; UV-DDB2; XPE,"DDB2-related xeroderma pigmentosum, group E, ddb-negative subtype",278740,MONDO:0010213,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000491; HP:0000509; HP:0000613; HP:0000621; HP:0000656; HP:0000992; HP:0001009; HP:0001029; HP:0002671; HP:0002861; HP:0003079; HP:0004334; HP:0006739,10469312; 12812979; 8798680,29169765; 32530099; 34135938,DD; Skin; Cancer,,2017-09-01 16:19:15+00:00,
G2P00181,ERCC3,133510,3435,BTF2; RAD25; SSL2; XPB,"ERCC3-related xeroderma pigmentosum, group B",610651,MONDO:0012531,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000135; HP:0000252; HP:0000271; HP:0000407; HP:0000518; HP:0000568; HP:0000580; HP:0000648; HP:0000762; HP:0000765; HP:0000992; HP:0001019; HP:0001249; HP:0001251; HP:0001272; HP:0001347; HP:0001371; HP:0001480; HP:0001518; HP:0001808; HP:0002099; HP:0002119; HP:0002135; HP:0002299; HP:0002671; HP:0002719; HP:0003224; HP:0004315; HP:0004322; HP:0004334; HP:0005214; HP:0005328; HP:0006739; HP:0007479; HP:0007485; HP:0011400; HP:0012056,16947863; 4811796; 8408834,28913623; 30580289; 7746858; 8304337,DD; Skin; Cancer,,2024-08-20 14:10:55+00:00,
G2P00410,NF1,613113,7765,,NF1-related neurofibromatosis,162200,MONDO:0018975,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000028; HP:0000119; HP:0000152; HP:0000238; HP:0000256; HP:0000272; HP:0000286; HP:0000316; HP:0000358; HP:0000369; HP:0000465; HP:0000470; HP:0000478; HP:0000494; HP:0000501; HP:0000508; HP:0000707; HP:0000750; HP:0000818; HP:0000822; HP:0000915; HP:0000917; HP:0000924; HP:0000957; HP:0000997; HP:0001067; HP:0001250; HP:0001256; HP:0001324; HP:0001328; HP:0001480; HP:0001507; HP:0001548; HP:0001574; HP:0001626; HP:0001642; HP:0001684; HP:0001909; HP:0001920; HP:0002162; HP:0002385; HP:0002410; HP:0002414; HP:0002521; HP:0002650; HP:0002664; HP:0002666; HP:0002857; HP:0002858; HP:0002859; HP:0002864; HP:0002897; HP:0002967; HP:0003002; HP:0003011; HP:0004322; HP:0004482; HP:0005272; HP:0006851; HP:0007340; HP:0007565; HP:0009592; HP:0009732; HP:0009734; HP:0009735; HP:0009736; HP:0009737; HP:0010302; HP:0030052; HP:0040064; HP:0100697; HP:0100723,10677298; 10712197; 11258625; 11389087; 11704931; 12438263; 12483293; 12707950; 1302608; 13680360; 1377942; 15520408; 15523642; 1568247; 15948193; 1719426; 1745350; 1757093; 1783401; 1937470; 19449407; 19845691; 2134734; 2516456; 2517530; 2517531; 2517532; 30308447; 3141830; 3152467; 7485153; 7542886; 7550323; 7607663; 7633431; 7649559; 7655472; 7746388; 8317503; 8664912; 9003501; 9529361; 9668168,35187958; 36803641; 37038321; 37401974; 37460655; 37599594; 37635082; 37993698; 38318699; 38375876; 38469797; 38825366; 38862389; 38987187; 39105762; 39140979; 39225241; 39254838; 39270790; 39366539; 39380389; 39559002; 39608493; 39643432; 39674537; 39676297; 39722341; 39730180; 39759190; 39764141; 39773869; 39799317; 39848286; 39857730; 39868496; 39896307; 39906425; 39925447; 39932063; 39981478; 40009967; 40033916; 40051696; 40054547; 40068833; 40087579; 40113446; 40120336; 40133996; 40139761; 40167261; 40186343; 40209081; 40211109; 40225101; 40234075; 40235035; 40237330; 40244956; 40247846; 40248182; 40282482; 40289159; 40298431; 40299482; 40305081; 40327120; 40338995; 40342626; 40347251; 40357806; 40361417; 40390741; 40393479; 40402550; 40408086; 40410838; 40412721; 40417234; 40438280; 40467291; 40471421; 40493756; 40520921; 40551856; 40568288; 40591546; 40617948; 40625468; 40642196; 40686803; 40695499; 40697342; 40703410; 40703627; 40706993; 40707315; 40709404; 40736848; 40741214,DD; Skin; Cancer; Skeletal,,2023-05-24 09:07:27+00:00,
G2P00413,PTEN,601728,9588,BZS; MHAM; MMAC1; PTEN1; TEP1,PTEN-related hamartoma tumour syndrome (Cowden syndrome),158350,MONDO:0008021,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,frameshift_variant; missense_variant; regulatory_region_variant; splice_region_variant; stop_gained; whole_partial_gene_deletion,loss of function,evidence,destabilising LOF:evidence,"32350270 -> function: biochemical, protein expression; functional_alteration: non patient cells; models: non-human model organism, cell culture model",HP:0000006; HP:0000034; HP:0000040; HP:0000138; HP:0000160; HP:0000218; HP:0000221; HP:0000256; HP:0000327; HP:0000337; HP:0000343; HP:0000347; HP:0000365; HP:0000486; HP:0000494; HP:0000518; HP:0000538; HP:0000545; HP:0000646; HP:0000717; HP:0000750; HP:0000767; HP:0000771; HP:0000821; HP:0000836; HP:0000853; HP:0000854; HP:0000872; HP:0000956; HP:0000957; HP:0000972; HP:0000995; HP:0001012; HP:0001014; HP:0001028; HP:0001031; HP:0001102; HP:0001249; HP:0001250; HP:0001252; HP:0001256; HP:0001263; HP:0001382; HP:0001513; HP:0001626; HP:0001943; HP:0002007; HP:0002080; HP:0002194; HP:0002253; HP:0002558; HP:0002573; HP:0002576; HP:0002650; HP:0002808; HP:0002858; HP:0002890; HP:0003002; HP:0003005; HP:0003196; HP:0003198; HP:0003517; HP:0003593; HP:0003621; HP:0004099; HP:0004390; HP:0004422; HP:0004481; HP:0005280; HP:0005490; HP:0005584; HP:0006740; HP:0007074; HP:0007873; HP:0008897; HP:0010609; HP:0012032; HP:0012056; HP:0012114; HP:0012844; HP:0012846; HP:0040198; HP:0100646; HP:0500009,10051160; 10353779; 10777358; 11238682; 11536076; 12844284; 15805158; 17286265; 23160955; 32350270; 9140396; 9241266; 9259288; 9425889; 9467011; 9832031; 9832032,33227300; 33595755; 34106409; 34168854; 34184188; 34206559; 34259361; 34396903; 34409504; 34489750; 34524588; 34754688; 34763900; 34937768; 34944785; 34983360; 34984555; 35006113; 35106660; 35187600; 35241692; 35278038; 35471415; 35487765; 35487791; 35780606; 35913038; 35988965; 36082652; 36122333; 36148582; 36151877; 36162030; 36607858; 36672590; 36690897; 36717037; 36977604; 37008396; 37041709; 37090027; 37093598; 37205954; 37252796; 37336910; 37361526; 37398799; 37409736; 37414745; 37442961; 37451289; 37534462; 37606231; 37680909; 37800459; 37819013; 37895258; 37900693; 37979468; 38501559; 38505951; 38513346; 38546160; 38697906; 38763900; 38792950; 38845672; 39044874; 39048366; 39080810; 39119301; 39129943; 39156315; 39166269; 39250745; 39256443; 39526825; 39550275; 39610113; 39643599; 39644587; 39799389; 39812526; 39851805; 39920402; 39988627; 40070859; 40098637; 40120468; 40208419; 40230416; 40244911; 40261085; 40282429; 40407579; 40469941; 40478255; 40498496; 40564777; 40715013,DD; Cancer,,2025-05-08 12:16:01+00:00,
G2P00443,ERCC4,133520,3436,FANCQ; RAD1; XPF,ERCC4-related Fanconi anemia,615272,MONDO:0014108,biallelic_autosomal,,strong,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000252; HP:0000365; HP:0000490; HP:0000505; HP:0000648; HP:0000822; HP:0000958; HP:0000992; HP:0001256; HP:0001541; HP:0001620; HP:0002011; HP:0002370; HP:0002910; HP:0003079; HP:0003510; HP:0004326; HP:0006297; HP:0007485; HP:0007495; HP:0007587; HP:0008069; HP:0200034,17183314; 23623386; 23623389; 3372781; 8797827,16116422; 29105242; 29325523; 29403087; 30047418; 34135938; 36816046; 38644609; 39652212; 39769235,DD; Cancer,,2025-01-28 23:05:02+00:00,
G2P00486,EXT2,608210,3513,SOTV,EXT2-related multiple exostoses,133701,MONDO:0007586,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000896; HP:0000918; HP:0002318; HP:0002812; HP:0002857; HP:0003068; HP:0003105; HP:0003276; HP:0003406; HP:0003621; HP:0004322; HP:0006765; HP:0010049,9326317,10429361; 10671060; 10679937; 10738008; 11170095; 11432960; 11731209; 14872200; 15446535; 16088908; 16638657; 17301954; 17676624; 18373409; 18386362; 18666861; 19309273; 19344451; 19571069; 19839753; 20872591; 21039224; 21499719; 22820392; 23439489; 23629877; 25230886; 25520924; 26246518; 26690531; 26961984; 27748933; 27920806; 28466453; 28922105; 29277722; 29529714; 29541207; 30075207; 30105120; 30288735; 30334991; 30730578; 30806661; 31096510; 31853203; 32293802; 32522262; 33596140; 34280007; 34403521; 34956317; 35806987; 36247276; 36360300; 39927251; 9463333; 9489802,DD; Cancer; Skeletal,,2023-05-24 09:07:28+00:00,
G2P00680,RET,164761,9967,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET51,RET-related multiple endocrine neoplasia IIB,162300,MONDO:0008082,monoallelic_autosomal,potential secondary finding; restricted mutation set,definitive,altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,gain of function,inferred,,,HP:0000006; HP:0000179; HP:0000218; HP:0000574; HP:0000767; HP:0000951; HP:0001252; HP:0001263; HP:0001382; HP:0001519; HP:0001531; HP:0001761; HP:0002014; HP:0002019; HP:0002251; HP:0002253; HP:0002650; HP:0002666; HP:0002808; HP:0002865; HP:0003005; HP:0003198; HP:0003307; HP:0003528; HP:0003639; HP:0005994; HP:0006461; HP:0008208,11788682,21986619; 22429913; 22500673; 22729463; 22734615; 23114404; 23225389; 23242522; 23330657; 23455356; 23563004; 23617071; 23652676; 23663121; 23723040; 23744408; 23749818; 24331334; 24361808; 24613280; 24684035; 24784869; 24969991; 25027091; 25191209; 25759805; 26033033; 26071011; 26209941; 26494389; 26732158; 26850131; 27273837; 27594983; 27704398; 27717313; 27994876; 28435794; 28469506; 28578594; 28747092; 28799054; 28874394; 28951487; 28983374; 29049491; 29261189; 29336779; 29455549; 30013307; 30113649; 30135345; 30374431; 30536424; 30693022; 31471357; 31666091; 32190804; 32388798; 32802527; 32914730; 32948239; 33191720; 33450337; 33456245; 33754314; 33814184; 33827484; 34092334; 34156257; 34267909; 34307848; 34446941; 34987852; 35117658; 35341763; 35569068; 35990038; 36857021; 37193168; 37465121; 37588200; 37900832; 37908885; 38136118; 38339246; 38562350; 38817239; 39475814; 39512978; 39790937; 39839784; 39913251; 39926264; 40102260; 40110286; 40128946; 40340909; 40656247; 40671763,DD; Skin; Cancer,,2025-01-21 15:02:57+00:00,
G2P00718,WRAP53,612661,25522,FLJ10385; TCAB1; WDR79,WRAP53-related dyskeratosis congenita,613988,MONDO:0013520,biallelic_autosomal,,strong,absent gene product; altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,loss of function,inferred,,,HP:0000007; HP:0001000; HP:0001876; HP:0002164; HP:0002860; HP:0004808; HP:0005528; HP:0008404; HP:0012182; HP:0030438; HP:0030442,21205863; 29514627; 32303682; 34599657,30047419; 34484289; 34649303; 37184208,DD; Cancer,,2025-03-14 11:32:41+00:00,
G2P00733,EXT1,608177,3512,LGCR; LGS; TTV,EXT1-related multiple exostoses,133700,MONDO:0007585,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000076; HP:0000252; HP:0000365; HP:0000400; HP:0000414; HP:0000431; HP:0000490; HP:0000577; HP:0000750; HP:0000896; HP:0000918; HP:0001159; HP:0001249; HP:0001252; HP:0001382; HP:0001530; HP:0001760; HP:0001808; HP:0002002; HP:0002209; HP:0002318; HP:0002650; HP:0002788; HP:0002812; HP:0002857; HP:0003068; HP:0003105; HP:0003276; HP:0003406; HP:0003621; HP:0003691; HP:0003764; HP:0004322; HP:0005039; HP:0005743; HP:0006765; HP:0007595; HP:0010049; HP:0010230; HP:0030431,15253765; 7550340; 8981950; 9326317,10429361; 10679937; 11170095; 11180615; 11432960; 12032595; 12457403; 14556251; 15446535; 16088908; 16638657; 16879194; 17301954; 1757967; 17676624; 18216313; 18330718; 18373409; 18386367; 18478595; 18810975; 19309273; 19344451; 19571069; 19839753; 20025490; 20101682; 20618940; 21039224; 21488238; 21499719; 21948702; 22040554; 22315192; 22820392; 23439489; 23629877; 23832104; 23913778; 25116165; 25230886; 25421355; 25520924; 26269715; 26522117; 26690531; 26839764; 26961984; 27920806; 28053536; 28466453; 28922105; 29277722; 29529714; 30334991; 30632316; 30664192; 30806661; 31096510; 31853203; 31976145; 32293802; 32296131; 32522262; 33209724; 33596140; 34012378; 34956317; 35806987; 36247276; 36360300; 36443465; 36676722; 37217936; 39336760; 39690272; 39927251; 9150727; 9463333; 9521425,DD; Cancer; Skeletal,,2023-05-24 09:07:28+00:00,
G2P01011,GATA2,137295,4171,NFE1B,GATA2-related Emberger syndrome,614038,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000286; HP:0000465; HP:0000601; HP:0001004; HP:0001182; HP:0001876; HP:0002863,20803646; 21242295; 21670465; 21892158; 22996659; 24227816; 2543925,25397911; 25619630; 25676417; 25739845; 25879889; 25955867; 26252413; 26395816; 26710799; 26716079; 26748574; 27130863; 27232273; 27248996; 27481672; 27680514; 27799394; 27894982; 28179280; 28259234; 28271814; 28373026; 28440875; 28495695; 28495697; 28825694; 28947108; 29156497; 29178327; 29230432; 29375553; 29567757; 29588856; 29595235; 29605372; 29680795; 29724903; 29882021; 29906059; 29942189; 29988375; 30030275; 30101490; 30222640; 30303925; 30478525; 30573048; 30578959; 30697248; 30894283; 30928982; 30933029; 31106410; 31246134; 31322613; 31679001; 31933136; 32286542; 32433473; 32497548; 32558139; 32643807; 32682923; 33066218; 33363905; 33370941; 33410496; 33684095; 33714240; 33726626; 33759087; 34051752; 34387894; 34638133; 34670919; 34713225; 34893945; 35096640; 35273927; 35603181; 35769478; 36119727; 36357187; 36455197; 36726998; 36900380; 36937639; 37317175; 37325673; 37595058; 37680631; 37799757; 37837580; 38290790; 38563709; 39890964; 39976744; 40153067; 40311177; 40340131,DD; Cancer,,2016-11-29 13:19:27+00:00,
G2P01104,ERCC5,133530,3437,ERCM2; XPGC,"ERCC5-related xeroderma pigmentosum, group G",278780,MONDO:0010216,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000152; HP:0000252; HP:0000478; HP:0000518; HP:0000568; HP:0000707; HP:0000924; HP:0000992; HP:0001251; HP:0001257; HP:0001337; HP:0001507; HP:0001510; HP:0001574; HP:0001761; HP:0001939; HP:0002671; HP:0003011; HP:0003079; HP:0006739; HP:0012056; HP:0040064,11219864; 11228268; 11841555; 12060391; 23255472; 698096; 7951246; 8818951; 9096355,11764181; 24354460; 24700531; 25256075; 27051686; 27982466; 29130490; 30838033; 33219753; 33766032; 37848274; 40626125; 8317483,DD; Eye; Skin; Cancer,,2024-08-20 14:15:43+00:00,
G2P01207,NHP2,606470,14377,FLJ20479; NOLA2,NHP2-related dyskeratosis congenita,613987,MONDO:0009136,biallelic_autosomal,,moderate,absent gene product; altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,loss of function,inferred,,,HP:0000007; HP:0000029; HP:0001249; HP:0001394; HP:0001510; HP:0001873; HP:0001876; HP:0002164; HP:0002514; HP:0004808; HP:0005528; HP:0008404; HP:0012182; HP:0030438; HP:0030442,18523010; 30472699; 31985013; 37440454,20493861; 22160078; 27824607; 40073202; 40352450,DD; Cancer,,2025-03-14 11:48:48+00:00,
G2P01245,PMS2,600259,9122,H_DJ0042M02.9; HNPCC4; MLH4; PMS-2; PMSL2,PMS2-related constitutional mismatch repair deficiency syndrome (CMMRD),619101,MONDO:0030843,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000707; HP:0000957; HP:0000997; HP:0001438; HP:0001574; HP:0001871; HP:0001909; HP:0002664; HP:0002665; HP:0002671; HP:0002715; HP:0002859; HP:0002885; HP:0002888; HP:0003006; HP:0003011; HP:0004377; HP:0005584; HP:0009725; HP:0012114; HP:0012174; HP:0025031; HP:0030692; HP:0040274; HP:0040275,26318770; 7661930,21233718; 21376568; 21636617; 21674763; 22461402; 22577899; 22619739; 22846734; 22848017; 22892529; 23523847; 23582141; 23729388; 23837913; 24068316; 24072394; 24440087; 24443998; 24556086; 24710284; 24802709; 25209657; 25307252; 25430799; 25489705; 25534383; 25691505; 25761717; 25773960; 25883011; 26248088; 26293676; 26437257; 26544533; 26743104; 26746812; 26781822; 26808570; 27017609; 27017610; 27037742; 27435373; 27476653; 27601186; 28248820; 28334867; 28381238; 28503822; 28514183; 28562508; 28572265; 28600700; 29255760; 29286535; 29690800; 30013564; 30155321; 30415209; 30614234; 30631111; 30764633; 31273487; 31274699; 31319185; 31470178; 31501241; 31599855; 31815888; 31845022; 32141610; 32436921; 32773772; 32876971; 33247381; 33335961; 33530354; 33934415; 34221829; 34247610; 34626046; 34787334; 36360190; 36414603; 36731423; 36743879; 36801211; 36897649; 36942845; 37197747; 37422136; 37706607; 37775264; 37879520; 38552658; 38860976; 38912246; 39296872; 39797698; 39859102; 40546006,DD; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01270,TSC1,605284,12362,HAMARTIN; KIAA0243; LAM; TSC,TSC1-related tuberous sclerosis,191100,MONDO:0008612,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000006; HP:0000107; HP:0000169; HP:0000717; HP:0000821; HP:0000826; HP:0000957; HP:0001249; HP:0001328; HP:0001482; HP:0001716; HP:0002086; HP:0002514; HP:0002888; HP:0003812; HP:0005584; HP:0006772; HP:0007018; HP:0009592; HP:0009594; HP:0009716; HP:0009717; HP:0009718; HP:0009719; HP:0009720; HP:0009721; HP:0009722; HP:0009724; HP:0009727; HP:0009729; HP:0009734; HP:0010615; HP:0010762; HP:0011097; HP:0011798; HP:0200024,10053179; 10340649; 10823953; 18830229; 9242607,24495558; 24792497; 25927202; 26231267; 26408672; 26793902; 27406250; 27859028; 28178598; 28222202; 28496353; 28623545; 28663780; 28762286; 28771801; 28828560; 28887784; 28978585; 29052576; 29196670; 29281825; 29500070; 29572283; 29740858; 29881807; 29926239; 29932062; 29941212; 30185235; 30279084; 30325570; 30838928; 30868117; 30976976; 31018109; 31140686; 31525612; 31708865; 31855466; 32097503; 32313033; 32325422; 32479982; 32519125; 32555378; 32654957; 32765227; 32854808; 32953421; 33181865; 33298910; 33528079; 33578443; 33693890; 33834938; 34017900; 34298906; 34433328; 34466799; 34480426; 34513752; 34534018; 34730894; 34849272; 34993123; 35022853; 35430095; 35440050; 35596872; 35712104; 36232477; 36585068; 37063680; 37370942; 37536923; 37919037; 37946245; 38062975; 38107744; 38206725; 38508103; 38528770; 38658236; 38806662; 39432612; 39596632; 39827117; 39878611; 39882213; 39891979; 40072314; 40174488; 40217423; 40367637; 40376498; 40554861; 40579409; 40621273; 40634399; 40745330,DD; Eye; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01293,DKC1,300126,2890,CBF5; DKC; DYSKERIN; NAP57; NOLA4; XAP101,DKC1-related dyskeratosis congenita,305000,MONDO:0010584,monoallelic_X_hemizygous,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000028; HP:0000047; HP:0000071; HP:0000085; HP:0000252; HP:0000486; HP:0000498; HP:0000509; HP:0000518; HP:0000648; HP:0000653; HP:0000670; HP:0000939; HP:0000953; HP:0000975; HP:0001249; HP:0001251; HP:0001263; HP:0001321; HP:0001394; HP:0001419; HP:0001511; HP:0001596; HP:0001741; HP:0001807; HP:0001809; HP:0001873; HP:0001876; HP:0001882; HP:0001903; HP:0002043; HP:0002091; HP:0002165; HP:0002206; HP:0002216; HP:0002721; HP:0002745; HP:0002860; HP:0002863; HP:0004322; HP:0004334; HP:0004808; HP:0005212; HP:0005528; HP:0006480; HP:0007427; HP:0008404; HP:0008734; HP:0009926; HP:0012182; HP:0012189; HP:0030438; HP:0030442,10583221; 10700698; 9590285,10364516; 10438713; 10636732; 11259155; 11379875; 11491307; 11522545; 12186364; 12437656; 12513020; 12539238; 12737310; 14556776; 14648217; 15304085; 15613268; 15842668; 16140563; 16207588; 16332973; 17417794; 17825470; 18005359; 18627054; 18802941; 18938267; 19327580; 19419704; 19615640; 19879169; 20091372; 20493861; 20687509; 20954562; 21415081; 21601430; 21736606; 21931702; 22160078; 22664374; 22798484; 22814958; 23946118; 24284296; 24635067; 24914498; 25237198; 25455995; 25499969; 26951492; 27504423; 27824607; 29042228; 29081935; 29485835; 29804726; 30047419; 30185935; 30868555; 31269755; 31602194; 32166868; 32452087; 32554502; 32710892; 33165394; 33191321; 33734615; 35384376; 35463902; 36111181; 36309505; 37189188; 40189296; 40265669; 40634789; 9042917; 9886310,DD; Eye; Skin; Cancer,,2024-08-20 13:59:58+00:00,
G2P01390,ATM,607585,795,ATA; ATC; ATD; ATDC; TEL1; TELO1,ATM-related ataxia-telangiectasia,208900,MONDO:0008840,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000134; HP:0000246; HP:0000486; HP:0000524; HP:0000639; HP:0000778; HP:0000819; HP:0000823; HP:0000957; HP:0001250; HP:0001251; HP:0001260; HP:0001266; HP:0001315; HP:0001332; HP:0001336; HP:0001337; HP:0001595; HP:0001888; HP:0001909; HP:0001952; HP:0002110; HP:0002665; HP:0002720; HP:0002837; HP:0002894; HP:0003002; HP:0004322; HP:0005357; HP:0005407; HP:0006254; HP:0008348; HP:0008669,11826028; 11889466; 22345219; 2491181; 7792600; 8755918; 8808599; 8968760; 9443866; 9450874; 9521587; 9600235; 9781027; 9887333,26220245; 26594831; 26628246; 26846839; 27181190; 27871447; 27873105; 28082406; 28351596; 28477107; 28488180; 28543935; 28716242; 29034753; 29163336; 29249681; 29288088; 29492593; 29524103; 29564828; 29582093; 29600275; 29664460; 29671115; 30100180; 30124550; 30279714; 30339652; 30504431; 30523550; 30549301; 30685876; 30772474; 30816533; 30819809; 30854690; 30888062; 31257506; 31691010; 31709473; 31741144; 31762358; 31921190; 32095276; 32116070; 32259893; 32558426; 32655291; 32745970; 32775531; 32791865; 32818697; 32871349; 32918381; 32923878; 32999401; 33044027; 33376610; 33547824; 33630411; 33743388; 34234451; 34404412; 34424493; 34453918; 34582042; 34602955; 34628594; 34686943; 34882376; 35145552; 35146067; 35154108; 35221880; 35257272; 35586824; 35644065; 36077770; 36439585; 36544766; 36806980; 36860961; 37009283; 37075885; 37351254; 37564729; 37802069; 38327652; 38404774; 38570878; 38882696; 39149652; 39281240; 39678378; 39853455; 40211499; 40379838; 40564629; 40565533; 40649708,DD; Skin; Cancer,,2017-09-01 16:19:15+00:00,
G2P01446,SMARCA4,603254,11100,BAF190; BRG1; FLJ39786; HSNF2B; SNF2; SNF2-BETA; SNF2L4; SNF2LB; SWI2,SMARCA4-related rhabdoid tumor predisposition syndrome,613325,MONDO:0013224,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,,20137775; 21566516; 25060813,22426308; 34377707; 35126043; 38088151; 38751117; 39091105; 40068817,DD; Cancer,,2015-07-22 16:15:28+00:00,
G2P01459,SMAD4,600993,6770,DPC4; MADH4,SMAD4-related juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,175050,MONDO:0008278,monoallelic_autosomal,potential secondary finding,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000006; HP:0000152; HP:0000421; HP:0000707; HP:0000924; HP:0001009; HP:0001217; HP:0001297; HP:0001508; HP:0001574; HP:0001626; HP:0001634; HP:0001653; HP:0001871; HP:0001903; HP:0002014; HP:0002027; HP:0002035; HP:0002086; HP:0002408; HP:0002573; HP:0002576; HP:0002664; HP:0002672; HP:0002900; HP:0003003; HP:0003073; HP:0004394; HP:0004784; HP:0004942; HP:0006548; HP:0006574; HP:0006771; HP:0012126; HP:0025031; HP:0040064; HP:0040274,10328134; 10398437; 10455879; 10811127; 16613914; 26572829; 9582123; 9811934,24001356; 24676695; 25389115; 25432397; 25705527; 25931195; 26159157; 26171675; 26566607; 27081547; 27146957; 27212857; 27375208; 28131865; 28874286; 29634562; 29707409; 29794143; 30210120; 30244195; 30251589; 30521991; 30873576; 31107726; 31398735; 31455059; 31561016; 31594285; 31910860; 32487124; 32556653; 32573726; 32756122; 32842615; 32944796; 33032550; 33058509; 33097490; 33370972; 33919892; 34112136; 34143765; 34189096; 34476273; 34477067; 34504656; 34699658; 34872578; 35057835; 35075588; 35110986; 35128723; 35165143; 35471415; 35487765; 35487791; 35651452; 35851413; 35869926; 35908967; 35988962; 36011318; 36038259; 36049049; 36359527; 36447760; 36496093; 36531685; 36546711; 36582665; 36588762; 36809082; 36810341; 36950548; 37113581; 37354305; 37400896; 37639637; 37695357; 37731378; 37807723; 37816352; 37900118; 37951373; 38066625; 38146137; 38191939; 38575304; 38627541; 38777277; 39063183; 39518056; 39546055; 39694043; 39788978; 39829872; 39901690; 39939156; 40314862; 40372668,DD; Skin; Cancer,,2024-12-24 10:03:29+00:00,
G2P01466,XPA,611153,12814,XP1; XPAC,XPA-related xeroderma pigmentosum,278700,MONDO:0010210,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000119; HP:0000152; HP:0000252; HP:0000407; HP:0000478; HP:0000491; HP:0000509; HP:0000598; HP:0000613; HP:0000621; HP:0000656; HP:0000707; HP:0000924; HP:0000992; HP:0001009; HP:0001029; HP:0001249; HP:0001251; HP:0001257; HP:0001265; HP:0001266; HP:0001268; HP:0001272; HP:0001284; HP:0001507; HP:0001574; HP:0001626; HP:0001939; HP:0002542; HP:0002715; HP:0003011; HP:0003079; HP:0003510; HP:0004334; HP:0008639,10767341; 1339397; 1372102; 16098033; 2234061,10413020; 10699759; 20199544; 22081045; 24135642; 25256075; 25393472; 25913378; 26302748; 27982466; 29797530; 30077970; 31478152; 33672602; 34484303; 36893274; 39655645; 9535131; 9671271,DD; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01487,PTCH1,601309,9585,BCNS; NBCCS; PTCH,PTCH1-related Gorlin syndrome (basal cell nevus syndrome),109400,MONDO:0958174,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000119; HP:0000152; HP:0000175; HP:0000204; HP:0000238; HP:0000242; HP:0000256; HP:0000280; HP:0000303; HP:0000316; HP:0000431; HP:0000478; HP:0000486; HP:0000501; HP:0000518; HP:0000568; HP:0000612; HP:0000707; HP:0000766; HP:0000773; HP:0000892; HP:0000912; HP:0000924; HP:0001056; HP:0001144; HP:0001249; HP:0001270; HP:0001425; HP:0001574; HP:0001626; HP:0002007; HP:0002414; HP:0002650; HP:0002664; HP:0002671; HP:0002751; HP:0002885; HP:0002937; HP:0002948; HP:0003011; HP:0003828; HP:0004280; HP:0004795; HP:0005449; HP:0005462; HP:0005815; HP:0008422; HP:0009729; HP:0010044; HP:0010442; HP:0010603; HP:0010609; HP:0010610; HP:0010612; HP:0010617; HP:0010618; HP:0025031; HP:0040064; HP:0200021,12900905; 22572734; 8658145; 8681379,21188685; 21210781; 21368767; 21567912; 21651513; 21834051; 21907124; 22007994; 22190277; 22363371; 22559979; 22565648; 22711650; 23169491; 23746055; 24124115; 24486987; 24635088; 24659465; 24814739; 24941978; 25131638; 25600101; 25706929; 25727044; 25940061; 26409035; 26544948; 26768321; 26794802; 26840755; 26850131; 27081512; 27444290; 27510672; 27513585; 27533646; 27658957; 27857042; 28496998; 28596197; 28686751; 28733979; 28915250; 29485834; 29498494; 29544218; 29575684; 29706825; 29930296; 30181650; 30327736; 30962945; 30997576; 31120550; 31382775; 31533758; 31578813; 31644632; 31949694; 31966778; 32028043; 32045149; 32074614; 32716646; 32741058; 33542540; 33860896; 33864364; 33911485; 33911679; 33960642; 34239189; 34291140; 34494262; 34888241; 35229340; 35235545; 35437209; 35584264; 35678525; 36107625; 36265746; 37082289; 37160435; 37504252; 37564720; 37907964; 38440616; 38546523; 38768301; 38864234; 39295706; 39581763; 39907678; 40314658; 40317671; 40361976; 40725845; 40729247,DD; Eye; Skin; Cancer,,2018-01-22 17:16:17+00:00,
G2P01547,PALB2,610355,26144,FANCN; FLJ21816,PALB2-related Fanconi anemia,610832,MONDO:0012565,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000007; HP:0000252; HP:0000286; HP:0000316; HP:0000470; HP:0000957; HP:0001629; HP:0001915; HP:0002667; HP:0002885; HP:0003006; HP:0003221; HP:0008897; HP:0009778,17200671; 17200672,25337756; 25337757; 25337758; 26968956; 26990772; 32052252; 33772500; 35305044; 36966080; 37961416; 39696405,DD; Cancer,,2025-01-28 23:07:31+00:00,
G2P01559,FANCI,611360,25568,FLJ10719; KIAA1794,FANCI-related Fanconi anemia,609053,MONDO:0012186,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,,17452773; 26590883,20515746; 22720145; 25486561; 34310468; 36463940; 39095039,DD; Cancer,,2024-08-20 14:18:23+00:00,
G2P01636,TSC2,191092,12363,LAM; PPP1R160; TSC4; TUBERIN,TSC2-related tuberous sclerosis,613254,MONDO:0013199,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000107; HP:0000169; HP:0000717; HP:0000821; HP:0000826; HP:0000957; HP:0001249; HP:0001328; HP:0001482; HP:0001716; HP:0002514; HP:0002888; HP:0003812; HP:0005584; HP:0006772; HP:0007018; HP:0009592; HP:0009594; HP:0009716; HP:0009717; HP:0009718; HP:0009720; HP:0009721; HP:0009724; HP:0009727; HP:0009729; HP:0009734; HP:0010615; HP:0010762; HP:0011097; HP:0011798,10069705; 10206124; 11403047; 12192641; 12752578; 17120248; 19259131; 7581393; 8634701; 8824881; 8825048; 9302281; 9361032; 9463313,29941212; 30298907; 30838928; 30868117; 30976976; 31018109; 31140686; 31273045; 31317616; 31505689; 31525612; 31542468; 31708865; 31855466; 32097503; 32193183; 32216820; 32313033; 32325422; 32383331; 32519125; 32533299; 32555378; 32695431; 32765227; 32854808; 32953421; 33074564; 33177398; 33421197; 33517515; 33581549; 33693890; 33834938; 34017900; 34206526; 34258938; 34298906; 34344650; 34466799; 34480426; 34513752; 34534018; 34849272; 35060563; 35142283; 35430095; 35440050; 35585803; 35596872; 35712104; 36232477; 36422197; 36585068; 36689859; 36895714; 36979978; 37088138; 37173860; 37228977; 37294265; 37311496; 37370942; 37536923; 37800821; 37843443; 37892277; 37919037; 37937420; 37946245; 38025010; 38062975; 38206725; 38273422; 38412945; 38508103; 38658236; 38715652; 38806662; 39050051; 39323690; 39383590; 39549115; 39596632; 39827117; 39882213; 39891979; 39926610; 39959682; 40161113; 40174488; 40367637; 40376498; 40406687; 40553952; 40554861; 40579409; 40621273; 40722560; 40745330,DD; Eye; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01668,TERC,602322,11727,HTR; SCARNA19; TER; TR; TRC3,TERC-related dyskeratosis congenita,,MONDO:0007485,monoallelic_autosomal,potential secondary finding,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0001915; HP:0002878; HP:0004808; HP:0012182; HP:0030438; HP:0030442,12090986; 23329068,12539238; 14556776; 14630445; 15098033; 15613268; 15886322; 16207588; 16332973; 17640862; 17825470; 17913752; 18005359; 20493861; 20687509; 21189492; 21931702; 22160078; 22323451; 22341970; 23661544; 25237198; 26024875; 27587879; 27824607; 29483670; 29804726; 29980875; 33203829; 37189188; 38606545; 39780848; 40561208,DD; Skin; Cancer,,2022-08-03 13:33:24+00:00,
G2P01793,APC,611731,583,DP2; DP2.5; DP3; PPP1R46,APC-related adenomatous polyposis coli,,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0000152; HP:0000478; HP:0000670; HP:0000706; HP:0000707; HP:0000769; HP:0000818; HP:0000924; HP:0000953; HP:0001012; HP:0001574; HP:0002664; HP:0002884; HP:0002885; HP:0002895; HP:0003003; HP:0003549; HP:0003828; HP:0004394; HP:0004783; HP:0005227; HP:0006722; HP:0006744; HP:0006771; HP:0007649; HP:0008256; HP:0009592; HP:0010562; HP:0010619; HP:0011068; HP:0011069; HP:0025031; HP:0100245; HP:0100246; HP:0200040,10494086; 10562580; 10598803; 12136240; 1316610; 1324223; 15771908; 1651174; 1651563; 2164769; 27087319; 3039373; 7485167; 7661930; 7797123; 8019566; 8162051; 8252630; 8281160; 8931709; 9288102; 9487968; 9521420; 9603437; 9724771; 9916927; 9950370,,Eye; Skin; Cancer,,2025-01-16 11:53:50+00:00,
G2P01794,BAP1,603089,950,HUCEP-6; KIAA0272; UCHL2,BAP1-related tumor predisposition syndrome,614327,MONDO:0013692,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0002671; HP:0002858; HP:0005584; HP:0006770; HP:0007716; HP:0011524; HP:0012054; HP:0012055; HP:0012056; HP:0030078; HP:0100002,21874000; 21874003; 21941004; 23684012; 24855403; 27748099; 28793149; 31382694,,Eye; Skin; Cancer,,2024-12-13 09:51:03+00:00,
G2P01795,BMPR1A,601299,1076,ACVRLK3; ALK3; CD292,"BMPR1A-related juvenile polypopsis syndrome, infantile form",174900,MONDO:0017380,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003003; HP:0004784; HP:0012126; HP:0040274,10398437; 9582123; 9811934,,Cancer,,2025-01-14 16:08:56+00:00,
G2P01796,BRCA1,113705,1100,BRCC1; FANCS; PPP1R53; RNF53,BRCA1-related cancer,,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002; HP:0006725; HP:0012125; HP:0025318,10196379; 10417303; 10788334; 11039575; 11157798; 12014998; 18285836; 7545954; 7894491; 7894492; 7894493; 8644702; 8968716; 9150173; 9585617; 9616287; 9927062,,Cancer,,2022-12-07 14:55:09+00:00,
G2P01797,BRCA2,600185,1101,BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; XRCC11,BRCA2-related cancer,,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002; HP:0006725; HP:0012125; HP:0025318,11039575; 11062481; 11158174; 12085187; 12145750; 15750593; 8524414; 8589730; 8673090; 8673092; 9150155; 9585617,,Skin; Cancer,,2025-01-16 12:54:02+00:00,
G2P01798,CDH1,192090,1748,CD324; UVO; UVOMORULIN,"CDH1-related gastric cancer, familial diffuse, with or without cleft lip and/or palate",137215,MONDO:0100488,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002,12042667,,Cancer,,2016-11-29 13:19:26+00:00,
G2P01799,CDK4,123829,1773,PSK-J3,"CDK4-related melanoma, cutaneous malignant",609048,MONDO:0012183,monoallelic_autosomal,,definitive,uncertain,,gain of function,inferred,,,HP:0012056,7652577; 9425228,,Skin; Cancer,,2022-11-30 08:52:53+00:00,
G2P01800,CDKN2A,600160,1787,ARF; CAI2; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4A; P19; P19ARF,"CDKN2A-related melanoma, cutaneous malignant",155601,MONDO:0007964,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0002860; HP:0002861; HP:0006725; HP:0009592; HP:0012056; HP:0012142; HP:0012182; HP:0100242,10797439; 11506491; 11725203; 11726555; 17492760; 18178632; 20132244; 7624155; 7666917; 7670475; 7987387; 8153634; 8653684; 8727306; 9328469; 9516223; 9603434,,Skin; Cancer,,2017-09-01 16:19:15+00:00,
G2P01801,CEBPA,116897,1833,C/EBP-ALPHA; CEBP,"CEBPA-related leukemia, acute myeloid",601626,MONDO:0018874,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0004808,11242107; 12661007; 15575056,,Cancer,,2016-11-29 13:19:27+00:00,
G2P01802,CHEK2,604373,16627,BA444G7; CDS1; CHK2; HUCDS1; PP1425; RAD53,CHEK2-related cancer,609265,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002; HP:0005584; HP:0012125; HP:0100242,10617473; 11719428,,Cancer,,2025-01-15 09:51:09+00:00,
G2P01803,CYLD,605018,2584,CYLD1; KIAA0849; USPL2,"CYLD-related cylindromatosis, familial",132700,MONDO:0007565,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000006; HP:0003581; HP:0008069,10835629; 12190880; 12950348; 14632188; 16307661; 16922728; 19807742,,Skin; Cancer,,2018-07-05 15:56:39+00:00,
G2P01804,EPCAM,185535,11529,17-1A; 323/A3; BER-EP4; BEREP4; CD326; CO-17A; EGP-2; EGP34; EGP40; EP-CAM; ESA; GA733-2; HEA125; KS1/4; KSA; LY74; M4S1; MH99; MIC18; MK-1; MOC-31; MOC31; TACST-1; TACSTD1; TROP1,"EPCAM-related colorectal cancer, hereditary nonpolyposis",613244,MONDO:0013196,monoallelic_autosomal,,definitive,absent gene product,regulatory_region_variant,loss of function,inferred,,,HP:0009720; HP:0009725; HP:0012114; HP:0012125; HP:0025318; HP:0030409; HP:0030692; HP:0040274; HP:0040275,19098912; 21309036,,Cancer,Regulatory element for MSH2,2023-09-06 10:37:47+00:00,
G2P01805,ERCC2,126340,3434,EM9; MAG; MGC102762; MGC126218; MGC126219; XPD,"ERCC2-related xeroderma pigmentosum, group D",278730,MONDO:0010212,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002671; HP:0002860; HP:0012056,11443545; 11709541; 7585650; 7849702; 9101292,,Cancer,,2016-11-29 13:19:27+00:00,
G2P01806,FH,136850,3700,,FH-related leiomyomatosis and renal cell cancer,150800,MONDO:0007888,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000119; HP:0001574; HP:0001939; HP:0002664,11865300; 12772087; 15663510,,Skin; Cancer,,2017-09-01 16:19:15+00:00,
G2P01807,FLCN,607273,27310,BHD; DENND8B; MGC17998; MGC23445,FLCN-related Birt-Hogg-Dube syndrome,135150,MONDO:0800445,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0005584; HP:0011798; HP:0030436,12204536; 15657874; 17496196; 18234728; 19320655; 19562744; 20413710; 20522427,,Skin; Cancer,,2017-09-01 16:19:15+00:00,
G2P01808,MEN1,613733,7010,,MEN1-related multiple endocrine neoplasia,131100,MONDO:0007540,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002858; HP:0002893; HP:0002897; HP:0009720; HP:0012032; HP:0030405; HP:0100570; HP:0100641,10647896; 11134142; 12050235; 12417605; 15205994; 15240620; 15870131; 22275377; 9103196; 9215689; 9241276; 9361035; 9498491; 9554741; 9709921,,Skin; Cancer,,2023-01-19 11:49:51+00:00,
G2P01809,MET,164860,7029,DFNB97; HGFR; RCCP2,"MET-related renal cell carcinoma, papillary",605074,MONDO:0003789,monoallelic_autosomal,,definitive,uncertain,,gain of function,inferred,,,,9140397; 9563489,,Cancer,,2022-11-30 08:53:24+00:00,
G2P01811,MLH1,120436,7127,COCA2; FCC2; HNPCC; HNPCC2; MLH-1,MLH1-related constitutional mismatch repair deficiency syndrome (CMMRD),276300,MONDO:0010159,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000707; HP:0001574; HP:0001871; HP:0001909; HP:0002664; HP:0002665; HP:0002715; HP:0003011; HP:0004377; HP:0005584; HP:0009725; HP:0012114; HP:0025031; HP:0030692; HP:0040274; HP:0040275,17440981; 22692065; 26318770; 7661930; 9927033,,Skin; Cancer,,2016-11-29 13:19:28+00:00,
G2P01812,MUTYH,604933,7527,MYH,"MUTYH-related adenomas, multiple colorectal",608456,MONDO:0012041,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002862; HP:0006771; HP:0025318; HP:0030255; HP:0040275,11818965; 12393807; 12606733; 15690400,,Cancer,,2023-01-19 11:31:36+00:00,
G2P01813,NF2,607379,7773,ACN; BANF; MERLIN; MERLIN-1; SCH,NF2-related schwannomatosis,101000,MONDO:0008075,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0001067; HP:0002858; HP:0002888; HP:0009592; HP:0009594; HP:0009733; HP:0100008,17357086; 18072270; 18285426; 19124645; 19582488; 20930055; 35674741; 7666400; 7913580; 8379998; 8566958; 8757035,,Eye; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01814,PALB2,610355,26144,FANCN; FLJ21816,PALB2-related cancer,,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002; HP:0006725; HP:0025318,25337756; 26248842,,Cancer,,2025-01-28 23:08:10+00:00,
G2P01815,PMS2,600259,9122,H_DJ0042M02.9; HNPCC4; MLH4; PMS-2; PMSL2,PMS2-related Lynch syndrome,614337,MONDO:0013699,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0009720; HP:0009725; HP:0012114; HP:0012125; HP:0025318; HP:0030409; HP:0030692; HP:0040274; HP:0040275,14756672; 15887124; 16472587; 18178629; 28754778,,Skin; Cancer,,2024-04-30 13:45:24+00:00,
G2P01816,PRKAR1A,188830,9388,CNC1; PKR1; PRKAR1; PRKAR1ALPHA; TSE1,PRKAR1A-related Carney complex,160980,MONDO:0008057,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000854; HP:0002890; HP:0011672; HP:0011746; HP:0011760; HP:0025451; HP:0030428; HP:0100618; HP:0100619,10973256; 10974026; 11115848; 12424709; 15371594,,Skin; Cancer,,2025-01-27 14:30:56+00:00,
G2P01817,RB1,614041,9884,OSRC; PPP1R130; RB,RB1-related retinoblastoma,180200,MONDO:0018160,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002669; HP:0009919; HP:0012056; HP:0030408; HP:0030448,10486322; 12016586; 1352883; 16631255; 16988938; 17299438; 1881452; 2594029; 2601691; 7881418; 9341870; 9400934,,Eye; Cancer,,2017-08-30 19:31:16+00:00,
G2P01819,RET,164761,9967,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET51,RET-related medullary thyroid carcinoma,155240,MONDO:0007958,monoallelic_autosomal,,definitive,uncertain,,undetermined,inferred,,,HP:0002865,10323403; 11454140; 14602786; 15240641; 3697657; 7906866; 7915165; 8099202; 9111992; 9506724,,Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01820,RET,164761,9967,CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET51,RET-related multiple endocrine neoplasia IIA,171400,MONDO:0008234,monoallelic_autosomal,potential secondary finding,definitive,altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,gain of function,inferred,,,HP:0000006; HP:0000179; HP:0000218; HP:0000574; HP:0000767; HP:0000951; HP:0001252; HP:0001263; HP:0001382; HP:0001519; HP:0001531; HP:0001761; HP:0002014; HP:0002019; HP:0002251; HP:0002253; HP:0002650; HP:0002666; HP:0002808; HP:0002865; HP:0003005; HP:0003198; HP:0003307; HP:0003528; HP:0003639; HP:0005994; HP:0006461; HP:0008208,10522989; 11788682; 12466368; 15292360,,Skin; Cancer,,2025-03-14 11:53:44+00:00,
G2P01821,RHBDF2,614404,20788,FLJ22341; IRHOM2; RHBDL5; RHBDL6; TOC; TOCG,RHBDF2-related tylosis with esophageal cancer,148500,,monoallelic_autosomal,restricted mutation set,definitive,altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,gain of function,inferred,,,HP:0000152; HP:0000153; HP:0001036; HP:0001574; HP:0002664; HP:0007447; HP:0011459; HP:0025031; HP:0040064,13209063; 22265016; 22638770; 8666405,,Skin; Cancer,,2016-11-29 13:19:29+00:00,
G2P01822,RUNX1,151385,10471,AML1; AMLCR1; CBFA2; PEBP2A2,"RUNX1-related platelet disorder, familial, with associated myeloid malignancy",601399,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002665; HP:0004808; HP:0004812; HP:0006727,10508512; 11830488; 12060124; 18478040; 19357396,,Cancer,,2016-11-29 13:19:29+00:00,
G2P01823,SDHAF2,613019,26034,C11ORF79; FLJ20487; PGL2; SDH5,SDHAF2-related paragangliomas,601650,MONDO:0011121,monoallelic_autosomal,,definitive,altered gene product structure,inframe_deletion; inframe_insertion; missense_variant,undetermined,inferred,,,HP:0002864,24523625; 6286462,,Cancer,,2022-12-07 14:02:47+00:00,
G2P01824,SDHB,185470,10681,SDH; SDH1,SDHB-related gastrointestinal stromal tumor,606764,MONDO:0011719,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,,11073817; 11404820; 11505412; 12213855; 14685938; 14715873; 15531530; 16258955; 16405730; 20503330; 9438854; 9697690,,Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01825,SDHB,185470,10681,SDH; SDH1,SDHB-related paraganglioma and gastric stromal sarcoma,606864,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668; HP:0005584; HP:0100723,15383933; 17804857,,Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01826,SDHC,602413,10682,CYB560; CYBL; PGL3,SDHC-related paragangliomas,605373,MONDO:0011544,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668; HP:0005584; HP:0100723,11062460; 12658451; 15342702; 26273102,,Cancer,,2016-11-29 13:19:29+00:00,
G2P01828,SDHD,602690,10683,CYBS; PGL; PGL1,SDHD-related paragangliomas with or without deafness,,MONDO:0008192,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668; HP:0005584; HP:0100723,10657297; 11156372; 11323050; 11343322; 11391796; 11391798; 11605159; 12111639; 15032977; 15066320; 15531530; 18678321,,Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01830,TP53,191170,11998,LFS1; P53,TP53-related Li-Fraumeni syndrome,151623,MONDO:0018875,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0001909; HP:0002488; HP:0002667; HP:0002669; HP:0003002; HP:0006744; HP:0030448; HP:0100006,10484981; 1565143; 1565144; 15977174; 1644930; 1679237; 1683921; 1933902; 1978757; 2259385; 8118819; 8134127; 8649785; 9569035,,Cancer,,2016-11-29 13:19:29+00:00,
G2P01831,VHL,608537,12687,VHL1,VHL-related von Hippel-Lindau syndrome,193300,MONDO:0008667,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0006770; HP:0009711; HP:0010797; HP:0030393; HP:0030405,10533030; 12414898; 20583150; 7563486; 7784063; 8550742; 8956040,,Eye; Skin; Cancer,,2017-09-01 16:19:16+00:00,
G2P01832,PHOX2B,603851,9143,NBPHOX; PMX2B,PHOX2B-related neuroblastoma with Hirschsprung disease,613013,MONDO:0700041,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003006,12438263; 15024693; 16691592; 26798564,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01833,CDC73,607393,16783,C1ORF28; FIHP; HRPT1; HRPT2; PARAFIBROMIN,CDC73-related hyperparathyroidism-jaw tumour syndrome,145001,MONDO:0007768,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002667; HP:0002897; HP:0010784; HP:0030427,12434154,,Cancer,,2022-10-19 11:40:52+00:00,
G2P01834,MAX,154950,6913,BHLHD4; BHLHD5; BHLHD6; BHLHD7; BHLHD8,"MAX-related pheochromocytoma, susceptibility to",171300,MONDO:0008233,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668,24523625,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01835,TMEM127,613403,26038,FLJ20507; FLJ22257,"TMEM127-related pheochromocytoma, susceptibility to",171300,MONDO:0008233,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668; HP:0100723,21613359; 24334760,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01837,SUFU,607035,16466,PRO1280; SUFUH; SUFUXL,"SUFU-related medulloblastoma, associated with Gorlin syndrome",,,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002671; HP:0002858; HP:0002885,19533801,,Cancer,,2022-11-23 09:01:06+00:00,
G2P01838,KIT,164920,6342,C-KIT; CD117; PBT; SCFR,KIT-related familial gastro-intestinal stromal tumours,,,monoallelic_autosomal,,definitive,uncertain,,undetermined,inferred,,,HP:0100723,11073817,,Skin; Cancer,,2016-11-29 13:19:30+00:00,
G2P01839,GREM1,603054,2001,CKTSF1B1; CRAC1; DAND2; DRM; GREMLIN; HMPS,GREM1-related hereditary mixed polyposis,,MONDO:0011023,monoallelic_autosomal,,definitive,uncertain,,undetermined,inferred,,,HP:0030255; HP:0040275,22561515,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01840,MSH2,609309,7325,COCA1; HNPCC; HNPCC1; MSH-2,MSH2-related constitutional mismatch repair deficiency syndrome (CMMRD),619096,MONDO:0030840,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000707; HP:0001574; HP:0001871; HP:0001909; HP:0002664; HP:0002665; HP:0002715; HP:0003011; HP:0004377; HP:0005584; HP:0009725; HP:0012114; HP:0025031; HP:0030692; HP:0040274; HP:0040275,11809679; 26318770,,Skin; Cancer,,2016-11-29 13:19:30+00:00,
G2P01841,MSH6,600678,7329,GTBP; MSH-6,MSH6-related constitutional mismatch repair deficiency syndrome,619097,MONDO:0030841,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0001909; HP:0002665; HP:0004377; HP:0005584; HP:0009725; HP:0012114; HP:0030692; HP:0040274; HP:0040275,26318770,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01842,POLE,174762,9177,POLE1,POLE-related polymerase proofreading-associated polyposis,,,monoallelic_autosomal,,strong,uncertain,,undetermined,inferred,,,HP:0004783; HP:0005227; HP:0030692; HP:0040275,25860647,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01843,POLD1,174761,9175,CDC2; POLD,POLD1-related polymerase proofreading-associated polyposis,,,monoallelic_autosomal,,strong,uncertain,,undetermined,inferred,,,HP:0005227; HP:0012114; HP:0030692; HP:0040275,25860647,,Cancer,,2016-11-29 13:19:30+00:00,
G2P01844,NTHL1,602656,8028,NTH1; OCTS3,"NTHL1-related adenomatous polyposis, colorectal cancer, breast cancer and other tumours",,,biallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0003002; HP:0004783; HP:0006771; HP:0012114; HP:0030255; HP:0040275,25938944,,Cancer,,2024-02-29 15:26:16+00:00,
G2P01845,SMARCB1,601607,11103,BAF47; HSNFS; INI-1; INI1; PPP1R144; RDT; SFH1P; SNF5; SNF5L1; SNR1,SMARCB1-related schwannomatosis,162091,MONDO:0024517,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,,10521299; 10739763; 25335493; 9671307,,Cancer,,2025-01-27 22:40:20+00:00,
G2P01846,LZTR1,600574,6742,BTBD29; LZTR-1,LZTR1-related schwannomatosis,,MONDO:0008075,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0100008,25480913,,Cancer,,2023-09-06 11:03:09+00:00,
G2P01847,SDHA,600857,10680,FP; SDH2; SDHF,SDHA-related paragangliomas,614165,MONDO:0013602,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0002666; HP:0002668; HP:0100723,26273102,,Cancer,,2025-01-27 13:59:29+00:00,
G2P02586,WT1,607102,12796,AWT1; GUD; NPHS4; WAGR; WIT-2; WT-1,WT1-related Wilms tumour,194070,MONDO:0008679,monoallelic_autosomal,,definitive,absent gene product,,loss of function,inferred,,,HP:0000150; HP:0002667,20301471,,Cancer,,2019-03-07 17:40:59+00:00,
G2P03339,MSH2,609309,7325,COCA1; HNPCC; HNPCC1; MSH-2,MSH2-related Lynch syndrome,,MONDO:0005835,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000119; HP:0000152; HP:0000769; HP:0001574; HP:0002086; HP:0002664; HP:0009720; HP:0009725; HP:0012114; HP:0012125; HP:0025031; HP:0025318; HP:0030409; HP:0030692; HP:0040274,10051005; 10528862; 12658575; 12694232; 15042510; 16451135; 22781090; 23170986; 28754778; 7874129; 7937795; 8261515; 8723682; 9634524,,Skin; Cancer,,2023-09-06 11:24:36+00:00,
G2P03340,CDKN1B,600778,1785,KIP1; P27KIP1,CDKN1B-related multiple endocrine neoplasia,,MONDO:0017169,monoallelic_autosomal,,strong,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002893; HP:0002897; HP:0030405; HP:0100570,17030811; 30990521; 32232325,,Cancer,,2022-11-30 08:56:07+00:00,
G2P03346,ELANE,130130,3309,ELA2; HLE; HNE; NE; PMN-E,ELANE-related neutropenia,,,monoallelic_autosomal,,strong,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808,15642668,,Cancer,,2025-01-15 23:34:48+00:00,
G2P03348,SH2D1A,300490,10820,DSHP; EBVS; IMD5; LYP; MTCP1; SAP; XLP; XLPD,SH2D1A-related lymphoproliferative syndrome,,MONDO:0024551,monoallelic_X_hemizygous,,strong,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002665,20926771,,Cancer,,2022-11-30 08:57:16+00:00,
G2P03351,MITF,156845,7105,BHLHE32; MI; WS2; WS2A,"MITF-related melanoma, cutaneous malignant",614456,MONDO:0013759,monoallelic_autosomal,,limited,absent gene product; altered gene product structure,,gain of function,inferred,,,HP:0012056,22012259,,Cancer,MITF-E318K variant,2023-09-06 11:15:07+00:00,
G2P03352,CTR9,609366,16850,KIAA0155; P150TSP; SH2BP1; TSBP,CTR9-related Wilms tumour,,MONDO:0024676,monoallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002667,25099282; 29292210,,Cancer,,2022-11-30 09:01:59+00:00,
G2P03353,SMARCE1,603111,11109,BAF57,"SMARCE1-related meningioma, familial",607174,MONDO:0011789,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002858,25143307,,Cancer,,2022-11-30 09:03:38+00:00,
G2P03354,SEC23B,610512,10702,CDA-II; CDAII; CDAN2; HEMPAS,SEC23B-related Cowden syndrome,616858,MONDO:0014802,monoallelic_autosomal,,limited,uncertain,,gain of function,inferred,,,HP:0005584; HP:0012056; HP:0012114; HP:0012846; HP:0500009,26522472,,Cancer,,2022-11-30 08:49:50+00:00,
G2P03355,REST,600571,9966,DFNA27; NRSF; XBR,REST-related Wilms tumour,616806,MONDO:0014779,monoallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002667,26551668,,Cancer,,2022-11-30 09:04:27+00:00,
G2P03356,TRIM28,601742,16384,KAP-1; KAP1; PPP1R157; RNF96; TF1B; TIF1-BETA; TIF1B; TIF1BETA,TRIM28-related Wilms tumour,,MONDO:0024676,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002667,30885698; 33565090,,Cancer,,2022-11-30 09:15:20+00:00,
G2P03357,BARD1,601593,952,,"BARD1-related breast cancer, susceptibility to",,MONDO:0007254,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0003002,33471991; 37592023,,Cancer,,2022-11-30 09:15:47+00:00,
G2P03358,SQSTM1,601530,11280,A170; OSIL; P60; P62; P62B; PDB3,SQSTM1-related Paget disease of bone,167250,MONDO:0008176,monoallelic_autosomal,,limited,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002669,11992264; 12374763,,Cancer,,2022-11-30 09:16:18+00:00,
G2P03359,TINF2,604319,11824,TIN2,TINF2-related dyskeratosis congenita,,MONDO:0013522,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0012182; HP:0030438; HP:0030442,18252230; 18669893,,Cancer,,2022-11-30 09:16:59+00:00,
G2P03360,ITK,186973,6171,EMT; LYK; PSCTK2,ITK-related lymphoproliferative syndrome,,MONDO:0016537,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0012189; HP:0012191,19425169; 21109689; 22289921,,Cancer,,2022-11-30 09:17:34+00:00,
G2P03361,RTEL1,608833,15888,BK3184A7.3; C20ORF41; DKFZP434C013; KIAA1088; NHL; RTEL,RTEL1-related dyskeratosis congenita,615190,MONDO:0014076,monoallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0012182; HP:0030438; HP:0030442,23329068; 23453664,26022962; 26400640; 28495916; 30523160; 34894270; 35199181; 36655009; 36937416; 37189188; 39156922; 39279436; 40139649; 40199602; 40424856,DD; Skin; Cancer,,2024-12-24 10:10:42+00:00,
G2P03362,ACD,609377,25070,PIP1; PTOP; TINT1; TPP1,ACD-related dyskeratosis congenita,616553,MONDO:0014690,monoallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0012182; HP:0030438; HP:0030442,25205116; 25233904,,Cancer,,2025-01-14 15:11:14+00:00,
G2P03363,DDX41,608170,18674,ABS; MGC8828,"DDX41-related myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to",616871,MONDO:0014809,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0005506,25920683; 26712909,,Cancer,,2022-11-30 09:19:32+00:00,
G2P03364,MTAP,156540,7413,C86FUS; MSAP,MTAP-related diaphyseal medullary stenosis with malignant fibrous histiocytoma,112250,MONDO:0007205,monoallelic_autosomal,,strong,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002669; HP:0012315; HP:0100244,,,Cancer,,2022-11-30 09:19:59+00:00,
G2P03365,ALK,105590,427,ALK1; CD246,"ALK-related neuroblastoma, susceptibility to",613014,MONDO:0013083,monoallelic_autosomal,,definitive,uncertain,,gain of function,inferred,,,HP:0003006,18724359,,Cancer,,2025-01-16 11:52:14+00:00,
G2P03366,EGFR,131550,3236,ERBB; ERBB1; ERRP,"EGFR-related nonsmall cell lung cancer, susceptibility to",,MONDO:0008903,monoallelic_autosomal,,definitive,uncertain,,gain of function,inferred,,,HP:0030358,16258541,,Cancer,,2022-11-30 08:51:59+00:00,
G2P03367,AIP,605555,358,ARA9; FKBP16; FKBP37; XAP2,AIP-related pituitary adenoma predisposition,,MONDO:0007052,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002893,16728643; 17244780; 17360484,,Cancer,,2022-11-30 09:20:39+00:00,
G2P03368,RAD51C,602774,9820,FANCO; RAD51L2,RAD51C-related cancer,,,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0003002; HP:0025318,33471991,,Cancer,,2025-01-28 23:08:28+00:00,
G2P03369,STK11,602216,11389,LKB1; PJS,STK11-related Peutz-Jeghers syndrome,175200,MONDO:0008280,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0003002; HP:0004390; HP:0006725; HP:0030079; HP:0031498; HP:0031918; HP:0040274; HP:0040275; HP:0100526; HP:0100619,12372054; 15200509; 15617552; 15800014; 8439212; 9425897; 9428765,,Cancer,,2022-11-30 09:26:27+00:00,
G2P03376,POLH,603968,9181,RAD30A; XP-V,"POLH-related xeroderma pigmentosum, variant type",278750,MONDO:0010214,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000152; HP:0000478; HP:0000491; HP:0000509; HP:0000613; HP:0000621; HP:0000656; HP:0000707; HP:0000992; HP:0001009; HP:0001029; HP:0001574; HP:0001626; HP:0002664; HP:0002671; HP:0002715; HP:0002860; HP:0004334; HP:0006739; HP:0012056,10385124; 10398605,,Skin; Cancer,,2022-11-30 09:21:30+00:00,
G2P03381,MSH6,600678,7329,GTBP; MSH-6,MSH6-related Lynch syndrome,,MONDO:0005835,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0009720; HP:0012114; HP:0012125; HP:0025318; HP:0030409; HP:0030692; HP:0040274; HP:0040275,10508506; 28754778; 7604266; 8075649; 9354786,,Cancer,,2023-09-06 11:30:56+00:00,
G2P03382,MLH1,120436,7127,COCA2; FCC2; HNPCC; HNPCC2; MLH-1,MLH1-related Lynch syndrome,,MONDO:0005835,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0009720; HP:0012114; HP:0012125; HP:0025318; HP:0030409; HP:0030692; HP:0040274; HP:0040275,10598809; 12112654; 12124320; 12919137; 14635101; 15571801; 15923275; 16341550; 19142183; 2022152; 20533529; 20858721; 21785361; 28754778; 4063166; 7584997; 8128251; 8145827; 9245993; 9831355; 9927033; 9927034,,Cancer,,2023-09-06 11:21:03+00:00,
G2P01582,PDGFRB,173410,8804,CD140B; JTK12; PDGFR; PDGFR1,PDGFRB-related familial infantile myofibromatosis,228550,MONDO:0009227,monoallelic_autosomal,restricted mutation set,definitive,altered gene product structure,missense_variant,gain of function,inferred,,,HP:0003549; HP:0010614; HP:0020135,23731537; 23731542; 28334876; 30200486,24065723; 25158255; 25212438; 28162874; 28286173; 28298627; 28417142; 28639748; 28935882; 29325620; 29999524; 31004414; 31291054; 31474318; 32500973; 33495995; 33683022; 36201717; 36861440; 36862146; 37568122; 37780723; 39047938; 39141797; 39873217; 40632343,DD; Skin; Cancer,,2025-01-21 11:27:52+00:00,
G2P03384,TERT,187270,11730,EST2; HEST2; TCS1; TP2; TRT,TERT-related dyskeratosis congenita (monoallelic),613989,MONDO:0013521,monoallelic_autosomal,,strong,absent gene product; altered gene product structure,,loss of function,evidence,,16247010 -> function: biochemical & 38641551 -> function: biochemical; functional_alteration: non patient cells,HP:0004808; HP:0012182; HP:0030438; HP:0030442,16247010; 25067791; 30523342; 35927969; 38641551,12629597; 16627250; 16934504; 16990594; 17460043; 17825470; 17875000; 17913752; 18005359; 19208095; 19405848; 19782144; 19936245; 20007561; 20493861; 20502709; 20966039; 21349926; 21436073; 22476886; 22664374; 23000017; 23905534; 25237198; 25596800; 25940403; 26024875; 26576048; 27824607; 28495683; 29382801; 29449422; 29483670; 29804726; 29976374; 30047419; 30603600; 31119896; 32054657; 32315675; 32487952; 32744739; 33147109; 34043865; 37189188; 37397566; 37926112; 38940945; 39225247; 39263645; 39849589; 39866942; 40456748; 40561208,DD; Cancer,,2025-03-05 15:20:17+00:00,
G2P03386,RTEL1,608833,15888,BK3184A7.3; C20ORF41; DKFZP434C013; KIAA1088; NHL; RTEL,RTEL1-related dyskeratosis congenita,615190,MONDO:0014076,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,evidence,,"23329068 -> functional_alteration: patient cells & 23453664 -> function: biochemical; functional_alteration: patient cells & 23591994 -> function: protein expression; functional_alteration: patient cells & 23959892 -> function: protein expression, biochemical, protein interaction; functional_alteration: patient cells; rescue: cell culture model, patient cells",HP:0004808; HP:0012182; HP:0030438; HP:0030442,23329068; 23453664; 23591994; 23959892,23621889; 24009516; 26025130; 26329388; 26847928; 27128385; 27824607; 28495916; 28507545; 29296694; 29696773; 30523160; 31677132; 32710398; 33482595; 35199181; 36776130; 37189188; 37853975; 39279436; 39295224; 40424856,DD; Skin; Cancer,,2025-03-05 15:53:21+00:00,
G2P03387,PARN,604212,8609,DAN,PARN-related dyskeratosis congenita,616353,MONDO:0014600,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0012182; HP:0030438; HP:0030442,25893599; 26482878; 26810774,25893598; 26342108; 28414520; 30525901; 31448843; 32452087; 33035329; 33244623; 38767220; 39649862,DD; Cancer,,2022-11-30 13:42:42+00:00,
G2P03388,PDGFRA,173490,8803,CD140A; GAS9; PDGFR2,"PDGFRA-related gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial",175510,MONDO:0008285,monoallelic_autosomal,,definitive,uncertain,,gain of function,inferred,,,HP:0100723,17087943,,Cancer,,2022-11-30 13:49:14+00:00,
G2P03389,TGFBR1,190181,11772,ACVRLK4; ALK-5; ALK5; ESS1; MSSE; TBR-I; TBRI,TGFBR1-related multiple self-healing squamous epithelioma,,MONDO:0007566,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0001574; HP:0006739,21358634,,Skin; Cancer,,2022-11-30 13:52:00+00:00,
G2P03390,RAD51D,602954,9823,HSTRAD; R51H3; RAD51L3; TRAD,RAD51D related cancer,,,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0003002; HP:0025318,33471991,,Cancer,,2022-11-30 13:54:20+00:00,
G2P03391,DICER1,606241,17098,DICER; HERNA; K12H4.8-LIKE; KIAA0928; MNG1,DICER1-related tumor predisposition,,,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0000854; HP:0002890; HP:0002898; HP:0006743; HP:0009726; HP:0030071; HP:0030408; HP:0031918; HP:0040277; HP:0100528; HP:0100728; HP:0100836,19556464; 21036787; 21205968; 21882293; 25209242; 25836323; 26566882; 9295070; 9345104,,Cancer,,2022-11-30 14:04:03+00:00,
G2P03402,CTC1,613129,26169,AAF132; C17ORF68; FLJ22170,CTC1-related dyskeratosis congenita,,MONDO:0015780,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0004808; HP:0012182; HP:0030438; HP:0030442,22532422,,Cancer,,2023-01-19 08:36:54+00:00,
G2P03403,ATM,607585,795,ATA; ATC; ATD; ATDC; TEL1; TELO1,ATM-related cancer,,,monoallelic_autosomal,,definitive,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0002894; HP:0003002,33471991; 34529012,,Cancer,,2025-01-14 15:29:09+00:00,
G2P03404,PTPN13,600267,9646,PTP-BAS; PTP-BL; PTP1E; PTPL1,PTPN13 related predisposition to bone marrow failure,,,biallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0006721,35643866,,Cancer,,2023-02-22 15:44:26+00:00,
G2P03405,MBD4,603574,6919,MED1,MBD4-related multi-tumour predisposition syndrome,,,biallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0007716; HP:0200063,35460607,,Cancer,,2023-02-22 16:06:31+00:00,
G2P03406,KDM1A,609132,29079,AOF2; BHC110; KDM1; KIAA0601; LSD1,KDM1A-related GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome,,,monoallelic_autosomal,,moderate,absent gene product; altered gene product structure,,loss of function,inferred,,,HP:0003118,34655521,,Cancer,,2023-02-23 07:49:12+00:00,
G2P03407,POLR2A,180660,9187,POLR2; POLRA; RPB1,POLR2A-related predisposition to ependymoma,,,monoallelic_autosomal,,limited,altered gene product structure,,undetermined,inferred,,,,35689525,,Cancer,,2025-01-16 11:32:00+00:00,
G2P03408,ARHGAP36,300937,26388,FLJ30058,ARHGAP36-related Bazex-Dupre-Christol basal cell carcinoma susceptibility syndrome,,,monoallelic_X_heterozygous,,moderate,altered gene product structure,regulatory_region_variant,undetermined,inferred,,,HP:0002671; HP:0008070,35986704,,Cancer,,2023-09-06 10:22:20+00:00,
G2P03478,ATRIP,606605,33499,FLJ12343; MGC20625; MGC21482; MGC26740,"ATRIP-related breast cancer, susceptibility to",,MONDO:0007254,monoallelic_autosomal,,moderate,absent gene product,,undetermined,inferred,,,HP:0003002,36977412; 37592023,,Cancer,,2023-09-06 10:16:37+00:00,
G2P03479,LZTR1,600574,6742,BTBD29; LZTR-1,"LZTR1-related breast cancer, susceptibility to",,MONDO:0007254,monoallelic_autosomal,,moderate,uncertain,,undetermined,inferred,,,HP:0003002,37592023,,Cancer,,2023-09-06 11:05:31+00:00,
G2P03480,MAP3K1,600982,6848,MAPKKK1; MEKK; MEKK1,"MAP3K1-related breast cancer, susceptibility to",,MONDO:0007254,monoallelic_autosomal,,moderate,absent gene product,,undetermined,inferred,,,HP:0003002,37592023,,Cancer,,2023-09-06 11:08:47+00:00,
G2P03527,CHEK2,604373,16627,BA444G7; CDS1; CHK2; HUCDS1; PP1425; RAD53,CHEK2-related cancer predisposition,,,biallelic_autosomal,,definitive,absent gene product; altered gene product structure,intron_variant; missense_variant; stop_gained,loss of function,inferred,,,,,,Cancer,,2025-03-14 12:02:17+00:00,
G2P03538,NPAT,601448,7896,E14; P220,NPAT-related cancer,,,monoallelic_autosomal,,moderate,decreased gene product level,stop_gained,loss of function,inferred,,,,38778081,,Cancer,,2025-03-14 12:04:00+00:00,
G2P01584,SPRTN,616086,25356,C1ORF124; DKFZP547N043; DVC1; SPARTAN,SPRTN-related progeria and hepatocellular carcinoma,616200,MONDO:0014527,biallelic_autosomal,,limited,altered gene product structure,frameshift_variant; inframe_deletion; inframe_insertion; missense_variant,undetermined,inferred,,,,25261934,25352099,DD; Skin; Cancer,,2025-07-23 10:45:18+00:00,
